Exostemtech Venture Capital
2 known investors
Exostemtech develops exosome-based therapeutics using platform technologies derived from adult stem cells for treating diseases including osteoarthritis, obesity, diabetes, fatty liver disease, and fibrosis. The company operates in the biotechnology and therapeutic drug development sector.
Investors · 2
Frequently asked questions
- What does Exostemtech Venture Capital do?
- Exostemtech develops exosome-based therapeutics using platform technologies derived from adult stem cells for treating diseases including osteoarthritis, obesity, diabetes, fatty liver disease, and fibrosis. The company operates in the biotechnology and therapeutic drug development sector.
- Who are Exostemtech Venture Capital's investors?
- Exostemtech Venture Capital's investors include IMM Investment Japan, We Ventures.